Based on 1 analyst offering 12 month price targets for Silexion Therapeutics Corp
Min Forecast
$9.00+587.02%
Avg Forecast
$9.00+587.02%
Max Forecast
$9.00+587.02%
Should I buy or sell SLXN stock?
Based on 1 analyst offering ratings for Silexion Therapeutics Corp.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SLXN's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates SLXN as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -9.02% per year. Learn More
Be the first to know when Wall Street analysts revise their SLXN stock forecasts and price targets.
Is Silexion Therapeutics Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: SLXN) stock is to Strong Buy SLXN stock.
Out of 1 analyst, 1 (100%) are recommending SLXN as a Strong Buy, 0 (0%) are recommending SLXN as a Buy, 0 (0%) are recommending SLXN as a Hold, 0 (0%) are recommending SLXN as a Sell, and 0 (0%) are recommending SLXN as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year SLXN price target, the average SLXN price target is $9.00, with the highest SLXN stock price forecast at $9.00 and the lowest SLXN stock price forecast at $9.00.
The Wall Street analyst predicted that Silexion Therapeutics's share price could reach $9.00 by Nov 1, 2025. The average Silexion Therapeutics stock price prediction forecasts a potential upside of 587.02% from the current SLXN share price of $1.31.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.